Sugar Control 132 mg/.6g
MORUS ALBA LEAF · TABLET · Bispit Canada Ltd.
Sugar Control is a tablet containing morus alba leaf at 132 mg/.6g, taken oral. Manufactured by Bispit Canada Ltd..
Key Facts
- Brand Name
- Sugar Control
- Generic Name
- MORUS ALBA LEAF
- NDC Code (Product)
85631-008- Manufacturer
- Bispit Canada Ltd.
- Strength
- 132 mg/.6g
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Marketing Start
- 09/04/2025
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
Suitable for: People with diabetes.1. individuals who enjoy sweets, refinedcarbohydrates, and high-carb foods and wantto manage their daily sugar intake;2. Individuals with initially high blood glucoselevels as this product can help promote glucosemetabolism and balance blood sugar;3. Has an ameliorating effect for individualswith insulin resistance, hyperglycemia, anddiabetes.
Dosage & Administration
Dosage: 2 tablets inthe morning and 2tablets in the evening
Warnings
1. As a chronic metabolic issue, high bloodsugar requires long-term management inconjunction with diet control and a suitableexercise plan. A low-carbohydrate, low-sugardiet is recommended.2. This product is not a substitute formedication.Individuals on long-term medicationshould consult their physician beforediscontinuing any medication and shouldmonitor their daily blood sugar levels.3. This product is not recommended forindividuals with hypoglycemia.4. Keep properly and out of reach of children.
Frequently Asked Questions
What is Sugar Control used for?
Sugar Control contains MORUS ALBA LEAF. It is a tablet taken oral. Consult your doctor for specific uses.
Is Sugar Control a controlled substance?
Sugar Control is not classified as a controlled substance by the DEA.
What is the generic name for Sugar Control?
The generic name for Sugar Control is MORUS ALBA LEAF. There are no other listed brand versions of MORUS ALBA LEAF.
What is the NDC code for Sugar Control 132 mg/.6g?
The NDC (National Drug Code) for Sugar Control 132 mg/.6g is 85631-008, listed by Bispit Canada Ltd..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)